TRAPPC5

Across TCGA pan-cancer cohorts, TRAPPC5 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated TRAPPC5 data layer compared with 23 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher TRAPPC5 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated TRAPPC5 expression acts as an unfavorable survival marker, although some lineages such as UCEC and LSCC show a favorable association.

UCEC, LSCC, and CCRCC are the cancer types where TRAPPC5 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	All	1.000	0.881	.010	24	view →
LSCC	DFS	Median	All	0.815	0.587	.005	20	view →
CCRCC	DFS	Median	All	0.837	0.636	.008	6	view →
PDAC	DFS	Quartile	III,IV	0.381	0.892	.026	3	view →
HNSC	OS	Median	All	0.784	0.627	.032	2	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

TRAPPC5–UCEC (OS)

Open the UCEC breakdown →